Perrigo | PRGO - Операционный доход





Операционный доход Изменить Дата
AbbVie USD 4.73B 1.08B 2026-03
Abbott USD 1.85B 399M 2026-03
Bayer EUR 3.53B 2.42B 2026-03
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Coherus Biosciences USD -39.08M 3.65M 2025-12
Corcept Therapeutics USD -49.6M 54.09M 2026-03
Dr.Reddys Laboratories INR 888M 13.05B 2026-03
Eli Lilly USD 9.78B 792M 2026-03
J&J USD 6.62B 1.03B 2026-03
Merck USD -1.88B 8.12B 2026-03
Nestle CHF 6.84B 293M 2025-12
Pacira USD 4.62M 1.43M 2026-03
Perrigo USD 33.6M 50.8M 2026-03
Pfizer USD 4.99B 340M 2026-03
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 75.49M 7M 2026-03
Reckitt Benckiser GBP 747M 92M 2024-12
Sanofi EUR 1.94B 239M 2026-03
Supernus Pharmaceuticals USD -35.25M 49.07M 2026-03
Teva Pharmaceutical Industries USD 758M 271M 2026-03
Xeris Pharmaceuticals USD 16.77M 10.04M 2025-12
Zoetis USD 865M 30M 2026-03